Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut mycobiota alterations in patients with COVID-19 and H1N1 infections and their associations with clinical features
Longxian Lv, Silan Gu, Huiyong Jiang, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly
Fen Zhang, Dominik Aschenbrenner, Ji Youn Yoo, et al.
The Lancet Microbe (2022) Vol. 3, Iss. 12, pp. e969-e983
Closed Access | Times Cited: 219
Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
Fen Zhang, Raphaela Iris Lau, Qin Liu, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 5, pp. 323-337
Open Access | Times Cited: 188
Fungi as mediators linking organisms and ecosystems
Mohammad Bahram, Tarquin Netherway
FEMS Microbiology Reviews (2021) Vol. 46, Iss. 2
Open Access | Times Cited: 136
Gut Microbiome Alterations in COVID-19
Tao Zuo, Xiaojian Wu, Weiping Wen, et al.
Genomics Proteomics & Bioinformatics (2021) Vol. 19, Iss. 5, pp. 679-688
Open Access | Times Cited: 119
Fungal microbiota sustains lasting immune activation of neutrophils and their progenitors in severe COVID-19
Takato Kusakabe, Woan-Yu Lin, Jin‐Gyu Cheong, et al.
Nature Immunology (2023) Vol. 24, Iss. 11, pp. 1879-1889
Open Access | Times Cited: 43
The faecal metabolome in COVID-19 patients is altered and associated with clinical features and gut microbes
Longxian Lv, Huiyong Jiang, Yanfei Chen, et al.
Analytica Chimica Acta (2021) Vol. 1152, pp. 338267-338267
Open Access | Times Cited: 77
Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review
Yeganeh Farsi, Azin Tahvildari, Mahta Arbabi, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 62
Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling
Leila B. Giron, Michael J. Peluso, Jianyi Ding, et al.
JCI Insight (2022) Vol. 7, Iss. 15
Open Access | Times Cited: 49
Microbiota and COVID-19: Long-term and complex influencing factors
Jiaqi Gang, Haiyu Wang, Xiangsheng Xue, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 47
COVID-19-associated candidiasis and the emerging concern of Candida auris infections
Chin-Shiang Tsai, Susan Shin‐Jung Lee, Wan-Chen Chen, et al.
Journal of Microbiology Immunology and Infection (2022) Vol. 56, Iss. 4, pp. 672-679
Open Access | Times Cited: 38
Enterotypes of the human gut mycobiome
Senying Lai, Yan Yan, Yanni Pu, et al.
Microbiome (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 36
The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment
Man Wang, Yuan Zhang, Chunmei Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 29
Cross-talk between immune system and microbiota in COVID-19
Shaghayegh Baradaran Ghavami, Mahsa Pourhamzeh, Maryam Farmani, et al.
Expert Review of Gastroenterology & Hepatology (2021) Vol. 15, Iss. 11, pp. 1281-1294
Open Access | Times Cited: 45
Role of the Microbiome in the Pathogenesis of COVID-19
Rituparna De, Shanta Dutta
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 31
Immunoregulatory Intestinal Microbiota and COVID-19 in Patients with Type Two Diabetes: A Double-Edged Sword
Pavlo Petakh, Iryna Kamyshna, Andriy Nykyforuk, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 477-477
Open Access | Times Cited: 30
Robust cross-cohort gut microbiome associations with COVID-19 severity
Junhui Li, Tarini Shankar Ghosh, Rachel MacCann, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 20
Gut microbiota in COVID-19: new insights from inside
Bingqian Zhou, Xiaoqi Pang, Jingyi Wu, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 17
The gut-lung axis: the impact of the gut mycobiome on pulmonary diseases and infections
Emily A Sey, Adilia Warris
Oxford Open Immunology (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 7
Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity
Yuichi Maeda, Daisuke Motooka, Takahiro Kawasaki, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 27
COVID-19 and Plethora of Fungal Infections
Reetu Kundu, Nidhi Singla
Current Fungal Infection Reports (2022) Vol. 16, Iss. 2, pp. 47-54
Open Access | Times Cited: 23
High Incidence of Candidemia in Critically Ill COVID-19 Patients Supported by Veno-Venous Extracorporeal Membrane Oxygenation: A Retrospective Study
Francesco Alessandri, Giancarlo Ceccarelli, Giuseppe Migliara, et al.
Journal of Fungi (2023) Vol. 9, Iss. 1, pp. 119-119
Open Access | Times Cited: 15
Candida in COVID-19: Gut-Lung Axis, Dysbiosis, and Infections
Milena Kordalewska, David S. Perlin
Current Fungal Infection Reports (2023)
Open Access | Times Cited: 13
The human gut mycobiome and the specific role of Candida albicans: where do we stand, as clinicians?
S Musumeci, Matteo Coen, Antonio Leidi, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 1, pp. 58-63
Open Access | Times Cited: 28
Bacterial and Fungal Gut Dysbiosis and Clostridium difficile in COVID-19
Laura Linares-García, María E. Cárdenas-Barragán, Winston Hernández-Ceballos, et al.
Journal of Clinical Gastroenterology (2022) Vol. 56, Iss. 4, pp. 285-298
Open Access | Times Cited: 21
A ‘Multiomic’ Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019
Chiara Pozzi, Riccardo Levi, Daniele Braga, et al.
Gastro Hep Advances (2022) Vol. 1, Iss. 2, pp. 194-209
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top